Effectiveness of SMS in Diabetes Control
SMSaludD
Effectiveness of Sending Sms Text Messages to Mobile Phone Patients to Remind Upcoming Appointments and Improve the Control of Diabetic Patients in Primary Care
1 other identifier
interventional
117
1 country
1
Brief Summary
Introduction: The Spanish Society of Family and Community Medicine, started the Program of Preventive Activities and Health Promotion, which generates periodic recommendations of preventive methods based on scientific evidence. In the last update it has become evident the need of modifications to adapt the program to modern times and focuses on improving accessibility and offering more flexible responses to users of the program. In this sense, the mobile phone technology could be useful, specifically the messaging service to remind patients their appointments and increase attendance rates. Main objective Compare the percentage of patients in the intervention group compared with the control group who achieved a figure of HbA1c \<7% in 2013.Design: single blind Randomized Clinical Trial. Study population: Patients with diabetes with or without hypertension or lipid metabolism disorder, over 18 years, belonging to the Public Health System of Basque Country (primary care) meeting the inclusion / exclusion criteria. Sample size: 238 patients (119 per arm) to detect a difference of 16% in the percentage of patients with HbA1c lower than 7% between groups: Short Messages Standard (SMS) group: Mobile messages reminding the next review of Papps. Control group: Routine clinical practice. Statistical analysis: The relationship between the intervention received and the main variable (compliance with preventive activities at 12 months) were analyzed using a logistic regression model.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable diabetes
Started Jun 2013
Typical duration for not_applicable diabetes
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 10, 2013
CompletedFirst Posted
Study publicly available on registry
January 21, 2013
CompletedStudy Start
First participant enrolled
June 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2015
CompletedJuly 20, 2016
July 1, 2016
2.3 years
January 10, 2013
July 19, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Compare the percentage of patients in the intervention group versus the control group who get a HbA1c below 7%
12 months
Secondary Outcomes (6)
Compare the mean change in HbA1c values between SMS group patients and control patients
6 and 12 months
Compare the percentage of patients in the intervention group compared with the control group that meet the following preventive recommendations
12 months
In patients with predictive risk index <1.5, to compare the incidence of diabetic complications in each group
12 months
Evaluate the percentage of patients who are controlled. We consider controlled patient when HbA1C <7%, BP <140/80 and cardiovascular risk <20% measured by the scale of Heart Register of Gerona (REGICOR)
6 and 12 months
To identify factors associated with better compliance of preventive activities in both groups
12 months
- +1 more secondary outcomes
Study Arms (2)
CONTROL GROUP
NO INTERVENTIONROUTINE CLINICAL PRACTICE
SMS MESSAGING
EXPERIMENTALSMS MESSAGES TO MOBILE PHONE TO REMEMBER THE NEXT CONTROL OF GLYCATED HEMOGLOBIN
Interventions
SMS MESSAGING TO MOBILE PHONE TO REMEMBER THE NEXT CONTROL OF GLYCATED DIABETES
Eligibility Criteria
You may qualify if:
- Type 2 diabetic patients with or without hypertension or lipid metabolism disorder,
- Aged between 35 and 74 years old with or without hypertension or lipid metabolism disorder,
- Mobile phone holder,
- Able to read messages via mobile phone.
You may not qualify if:
- Pregnant women,
- Patients whose next date for HbA1c control is less than 2 months
- Patients with HbA1c \<7%
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Comarca Araba
Vitoria-Gasteiz, Álava, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Epidemiologist
Study Record Dates
First Submitted
January 10, 2013
First Posted
January 21, 2013
Study Start
June 1, 2013
Primary Completion
September 1, 2015
Study Completion
October 1, 2015
Last Updated
July 20, 2016
Record last verified: 2016-07